Newspaper article St Louis Post-Dispatch (MO)

Ritalin Treats Apathy in Patients with Alzheimers Disease

Newspaper article St Louis Post-Dispatch (MO)

Ritalin Treats Apathy in Patients with Alzheimers Disease

Article excerpt

Leslye Nathe did not realize the profound effect that Ritalin was having on her mothers Alzheimers disease until a doctor stopped the prescription.

Her mother, Susan Brown, 74, a resident at Provision Living in Webster Groves, began sleeping nearly all the time. And during rare moments, when she was awake, she was tearing the sheets off of her bed and scratching wounds into her arms.

She was like a child having a tantrum and she kept telling people to leave. She was very paranoid, Nathe said. She would beg me, Please, please get me some medication. Theres something wrong.

Brown had been taking Ritalin for many years even before she was diagnosed with Alzheimers, to treat attention deficit disorder and depression.

When her physician, Dr. George Grossberg, director of geriatric psychiatry at St. Louis University, heard about her alternating bouts of lethargy and meltdowns, he put Brown back on the Ritalin.

Her reaction to being taken off the drug was more extreme than usual, but it supported the long-held notion that Ritalin is key to controlling some Alzheimers symptoms.

Grossberg and a team of researchers at the university, recently received a $183,540 grant from Noven Pharmaceuticals Inc. to study Ritalin as a therapy for apathy and fall risk in Alzheimers patients. Both are common symptoms of Alzheimers disease, affecting about 70 percent patients who have it.

Noven is a joint-venture partner of Novartis Pharmaceuticals, which manufactures Ritalin. Novartis paid Grossberg $28,000 in 2010 to speak about its products to other physicians.

Grossberg said family members frequently notice that loved ones are indifferent, socially disengaged and have lost all enthusiasm.

Its serious couch-potatoism, and it drive relatives crazy, Grossberg said. Theres a lot of evidence that Ritalin has mood- elevating effects and also makes them more aware of their environment and obstacles. They also make better decisions.

Scientists are not sure what causes apathy in patients with Alzheimers disease but early data indicate that it might be related to a decrease in the transmission of dopamine, a feel-good chemical in the brain. Ritalin, which is commonly used to treat attention deficit disorder, increases the transmission of dopamine in the brain. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.